ABSTRACT Administration of monocrotaline, a pyrrolizidine alkaloid, to male Sprague-Dawley rats for up to three weeks increased dry lung weights by 64% and reduced the specific activity of lung angiotensin-converting enzyme activity by 64%. When the total activity per lung is calculated, however, there is no significant difference between control and monocrotaline-treated animals. The decrease in specific activity is due to increase in total lung protein (52% above control) and not to an actual reduction in the total angiotensin-converting enzyme activity in the lung.
Kay and his colleagues recently reported that pulmonary angiotensin-converting enzyme activity was reduced in monocrotaline-induced pulmonary hypertension' 2. We had conducted similar work in whole lungs3 and lung microsomes and had also been able to show a decrease in the activity of this enzyme when this was expressed per milligram of microsomal protein. Our conclusions, however, differ from those of Kay et With angiotensin-converting enzyme measurements this is difficult because the activity of the crude lung homogenate is quite low and possibly contaminated with non-specific peptidases.9 To measure the activity accurately, enrichment of the enzyme by differential centrifugation is necessary. This step introduces some variability into the assay. In addition, the activity is measured in a protein sample that is a fraction of the original protein, which also makes it difficult to extrapolate to activities for the entire lung. Despite these limitations, we calculated angiotensin-converting enzyme activity per lung based on the total activity of the pellet recovered after the 100 000 g spin because the enzyme activity per whole organ is more meaningful than the activity expressed per unit of protein (table) .
In conclusion, subacute administration of monocrotaline produces in the lungs and right heart all the changes seen after acute administration. These include pulmonary arterial hypertension,'0 right ventricular hypertrophy, increased lung mass, endothelial hyperplasia, and inhibition of serotonin transport.3 Inhibition of norepinephrine transport is seen with more severe damage." We have not seen inhibition of endothelial 5'-nucleotidase or angiotensin-converting enzyme activities. 
